SINGAPORE — (BUSINESS WIRE) — Prestige Biopharma Limited (KRX: 950210, hereafter referred to as 「Prestige」) and Intas Pharmaceuticals Limited (hereafter referred to as 「Intas」) today annou…
Prestige Biopharma and Intas Pharmaceuticals Announce Partnership to Commercialize Bevacizumab Biosimilar in the US, Europe, Canada, MENA, Brazil, Mexico, South Africa, CIS and the SEA countries
SINGAPORE — (BUSINESS WIRE) — Prestige Biopharma Limited (KRX: 950210, hereafter referred to as 「Prestige」) and Intas Pharmaceuticals Limited (hereafter referred to as 「Intas」) today annou…